|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/135 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 25/24 | (2006.01) |
| (11) | Number of the document | 3501542 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18215651.3 |
| Date of filing the European patent application | 2018-12-21 | |
| (97) | Date of publication of the European application | 2019-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2026-01-28 |
| (46) | Date of publication of the claims translation | 2026-05-25 |
| (30) | Number | Date | Country code |
| 201762609504 P | 2017-12-22 | US | |
| 201862663219 P | 2018-04-26 | US | |
| 201862663206 P | 2018-04-26 | US | |
| 201862667406 P | 2018-05-04 | US | |
| 201862675846 P | 2018-05-24 | US | |
| 201862755905 P | 2018-11-05 | US |
| (72) |
CANUSO, Carla , US
DALY, Ella , US
DREVETS, Wayne , US
LI, Honglan , US
HOUGH, David Wood , US
JANIK, Adam , US
OCHS-ROSS, Rachel , US
SINGH, Jaskaran , US
WAJS, Ewa , BE
ZANNIKOS, Peter , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Esketaminas depresijai gydyti |
| ESKETAMINE FOR THE TREATMENT OF DEPRESSION |